Assets Acquisition - Schedule of Fair Value of the Identifiable Assets (Details) |
Jun. 30, 2026
USD ($)
|
|---|---|
| Schedule of Fair Value of the Identifiable Assets [Abstract] | |
| Total consideration in cash | $ 552,730 |
| Assets acquired and liabilities assumed: | |
| Cash acquired | 9 |
| Original paid in capital paid to Hupan Pharmaceutical | 276,365 |
| Intangible assets – license of pharmaceutical distribution | 418,867 |
| Other payables | (37,794) |
| Deferred tax liabilities | (104,717) |
| Total assets acquired | $ 552,730 |
| X | ||||||||||
- Definition Amount of payable to hupan pharmaceutical. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of other payables. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of asset recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|